VR23

Item no.	M4985-50mg
Manufacturer	AbMole
CASRN	1624602-30-7
Amount	50mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Purity	0,9905
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Target Information	Proteasome
Molecular Weight	477, 88
Solubility	DMSO
Bioactivity information	VR23 is a small molecule that potently inhibited the activities of trypsin-like proteasomes (IC50 = 1 nM), chymotrypsin-like proteasomes (IC50 = 50-100 nM), and caspase-like proteasomes (IC50 = 3 μM).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M4985-50mg-safety-datasheet.pdf